Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.9M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
46.9M
-
Shares change
-
+11.1M
-
Total reported value, excl. options
-
$768M
-
Value change
-
+$182M
-
Put/Call ratio
-
6.17
-
Number of buys
-
45
-
Number of sells
-
-22
-
Price
-
$16.40
Significant Holders of Tyra Biosciences, Inc. - Common Stock (TYRA) as of Q1 2024
86 filings reported holding TYRA - Tyra Biosciences, Inc. - Common Stock as of Q1 2024.
Tyra Biosciences, Inc. - Common Stock (TYRA) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.9M shares
of 52.9M outstanding shares and own 88.58% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10.4M shares), Boxer Capital, LLC (6.45M shares), BVF INC/IL (4.66M shares), Canaan Partners XI LLC (4.41M shares), Nextech Invest Ltd. (4.06M shares), FMR LLC (3.98M shares), TCG Crossover Management, LLC (1.99M shares), Fairmount Funds Management LLC (1.39M shares), BlackRock Inc. (1.04M shares), and 5AM Venture Management, LLC (939K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.